ES2181873T3 - Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen. - Google Patents

Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen.

Info

Publication number
ES2181873T3
ES2181873T3 ES96906750T ES96906750T ES2181873T3 ES 2181873 T3 ES2181873 T3 ES 2181873T3 ES 96906750 T ES96906750 T ES 96906750T ES 96906750 T ES96906750 T ES 96906750T ES 2181873 T3 ES2181873 T3 ES 2181873T3
Authority
ES
Spain
Prior art keywords
contain
extracts
polyphenols
fractions
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96906750T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Giuseppe Mustich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11370887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181873(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2181873T3 publication Critical patent/ES2181873T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A23V2250/2132—Other phenolic compounds, polyphenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE LA PREPARACION DE NUEVAS FRACCIONES DE POLIFENOL DE CAMELLIA SINENSIS (TE), SU USO Y FORMULADOS QUE LAS CONTIENEN. LA INVENCION TRATA DE FORMA MAS ESPECIFICA DE LA PREPARACION DE EXTRACTOS PRIVADOS DE CAFEINA PERO QUE CONTIENEN LOS POLIFENOLES QUE DERIVAN DE LA EPIGALOCATEQUINA EN UNA PROPORCION NATURAL. ESTOS EXTRACTOS PUEDEN UTILIZARSE POR SI SOLOS, O COMBINADOS CON ANTIOXIDANTES LIPOFILOS, AMINOACIDOS SULFURADOS Y OLIGOELEMENTOS DE IMPORTANCIA BIOQUIMICA Y NUTRICIONAL. EL USO DE ESTOS NUEVOS EXTRACTOS, POR SI SOLOS O JUNTO CON OTROS PRINCIPIOS ACTIVOS, RESULTA DE INTERES EN EL CAMPO ALIMENTARIO, FARMACEUTICO Y COSMETICO.
ES96906750T 1995-03-14 1996-03-07 Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen. Expired - Lifetime ES2181873T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI000493A IT1275905B1 (it) 1995-03-14 1995-03-14 Frazioni polifenoliche di te', loro uso e formulazioni che le contengono

Publications (1)

Publication Number Publication Date
ES2181873T3 true ES2181873T3 (es) 2003-03-01

Family

ID=11370887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96906750T Expired - Lifetime ES2181873T3 (es) 1995-03-14 1996-03-07 Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen.

Country Status (16)

Country Link
US (2) US5989557A (es)
EP (1) EP0814823B1 (es)
JP (2) JP3264934B2 (es)
KR (1) KR100301678B1 (es)
CN (1) CN1138552C (es)
AT (1) ATE222113T1 (es)
AU (1) AU696676B2 (es)
CA (1) CA2215210C (es)
DE (1) DE69622998T2 (es)
DK (1) DK0814823T3 (es)
ES (1) ES2181873T3 (es)
IT (1) IT1275905B1 (es)
NO (1) NO326762B1 (es)
PT (1) PT814823E (es)
RU (1) RU2185070C2 (es)
WO (1) WO1996028178A1 (es)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
JP3213557B2 (ja) * 1996-11-18 2001-10-02 三井農林株式会社 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
CA2300118A1 (en) * 1997-08-14 1999-02-25 Joel Howard Glass Method for extracting synergistic and biological activity maintaining compound from camellia sinensis; an extracted compound and use of said compound in the food processing or pharmaceutical industry
DE19754940A1 (de) * 1997-12-12 1999-06-17 Siedler Siegfried Herstellung und Verarbeitung von Pflanzenauszügen, Extrakten und ätherischen Ölen
RU2175236C2 (ru) * 1998-03-11 2001-10-27 Научно-производственный центр "Борщаговский химико-фармацевтический завод" Способ получения суммы полифенолов
DE19824727A1 (de) * 1998-06-03 1999-12-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee
JP4507027B2 (ja) * 1998-12-04 2010-07-21 明治乳業株式会社 Ｍｍｐ阻害剤
US6210679B1 (en) 1999-01-07 2001-04-03 Hauser, Inc. Method for isolation of caffeine-free catechins from green tea
US6576275B1 (en) * 1999-02-02 2003-06-10 Archer-Daniels-Midland Company Process for extracting polyphenolic antioxidants from purine-containing plants
EP1153010A1 (en) * 1999-02-08 2001-11-14 Checkpoint Genetics, Inc. $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
SE9900473D0 (sv) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation
US6428818B1 (en) 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
US6410052B1 (en) 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6410061B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins as cancer specific proliferation inhibitors
US8372454B2 (en) * 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
US7611738B2 (en) * 2005-05-24 2009-11-03 Pom Wonderful, Llc Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof
EP1207862A2 (en) * 1999-06-07 2002-05-29 The University Of Sheffield Arthritis treatment
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
CN1089006C (zh) * 1999-08-13 2002-08-14 中国科学院生态环境研究中心 一种从茶叶提取活化的凝血因子十抑制组分（ati）方法
ATE346059T1 (de) 1999-08-16 2006-12-15 Dsm Ip Assets Bv Verfahren zu herstellung von epigallocatechin gallate
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
FR2798561B1 (fr) * 1999-09-21 2001-11-02 Jean Morelle Compositions destinees a l'usage alimentaire et cosmetique, caracterisees par leurs proprietes antilipoperoxydes
US6248341B1 (en) 2000-01-14 2001-06-19 Color Access, Inc. Method of treating topical angiogenesis-related disorders
AU783361B2 (en) * 2000-02-18 2005-10-20 Arch Development Corporation Polyhydroxylated benzene-containing compounds
KR100379323B1 (ko) * 2000-02-29 2003-04-08 삼아약품 주식회사 카테킨을 포함하는 관상동맥 재협착 예방 및 치료용 약학조성물
WO2001066714A1 (en) * 2000-03-10 2001-09-13 Kabushiki Kaisha Yakult Honsha α-AMYLASE ACTIVITY INHIBITORS
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
US6620452B1 (en) 2000-05-05 2003-09-16 American Fruit And Flavors Food additives having enlarged concentration of phenolics extracted from fruits and vegetables and process of obtaining the same
US6509054B1 (en) * 2000-05-05 2003-01-21 American Fruits And Flavors Food additives having enlarged concentration of phenolics extracted from fruits, and process of obtaining the same
US6254898B1 (en) * 2000-05-25 2001-07-03 Protective Factors, Inc. Nutraceutical composition for protection against solar radiation
US20020146472A1 (en) * 2000-11-15 2002-10-10 Chen Kuang Yu Black tea extract for prevention of disease
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
WO2002067965A1 (en) * 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
PT1372682E (pt) * 2001-03-15 2012-08-03 Proteotech Inc Catequinas para o tratamento de fibrilogénese em doença de alzheimer, doença de parkinson, amiloidose αa sistémica e outras perturbações amiloides
BRPI0214256B8 (pt) * 2001-11-19 2021-05-25 Medigene Ag medicamento
US20040142048A1 (en) * 2002-02-22 2004-07-22 Morre Dorothy M. Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
JP2004035550A (ja) * 2002-05-07 2004-02-05 Access Business Group Internatl Llc 植物栄養素栄養サプリメント
US20040097432A1 (en) * 2002-11-04 2004-05-20 Access Business Group International Llc. Method of reducing cholesterol
US7115283B2 (en) * 2003-05-06 2006-10-03 Access Business Group International Llc Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals
CN1874781B (zh) * 2003-09-08 2010-11-10 盖尼奥斯生物医学国际公司 用于癌症治疗的植物提取物的组合物
JP2007505934A (ja) * 2003-09-22 2007-03-15 ジェニアス バイオメド インターナショナル インコーポレイテッド 癌治療のためのＨｉｐｐｏｐｈａｅｒｈａｍｎｏｉｄｅｓ組成物
NZ545609A (en) * 2003-09-23 2009-08-28 Origin Biomed Inc Anhydrous topical formulation for polyphenols adsorbed to binding carrier
AU2004281525B2 (en) 2003-10-09 2010-01-28 Aresus Pharma GmbH The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
PL1722805T3 (pl) * 2004-01-12 2014-08-29 Akzo Nobel Surface Chemistry Llc Biologicznie czynne kompozycje z roślin Theacea oraz sposoby ich wytwarzania i zastosowanie
CN1319527C (zh) * 2004-01-17 2007-06-06 栾德刚 表没食子儿茶素没食子酸酯在制备预防和治疗因化疗引起脱发的药物中的应用
US7232585B2 (en) * 2004-06-24 2007-06-19 Xel Herbaceuticals, Inc. Green tea formulations and methods of preparation
EP1618793A1 (en) * 2004-07-20 2006-01-25 Cognis IP Management GmbH Extracts of Camellia sinensis with low alkaloid content
JP4702824B2 (ja) * 2004-07-22 2011-06-15 三井農林株式会社 茶ポリフェノール組成物及びその製造方法
US7666452B2 (en) * 2006-01-25 2010-02-23 Ito En, Ltd. Beverage comprising cathechins and caffeine
FR2876905B1 (fr) * 2004-10-22 2007-01-12 Silab Sa Procede d'obtention d'un principe actif a effet protecteur du cheveu, principe actif obtenu et compositions associees
GB2435166B (en) * 2004-11-04 2009-07-08 Univ Tsukuba High molecular weight polphenols extracted from fermented tea and a method of manufacturing a medicament for the prevention and treatment of diabetes
CN100413858C (zh) * 2004-11-23 2008-08-27 三达膜科技（厦门）有限公司 一种低咖啡因的高纯茶多酚的生产方法
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
RU2404742C2 (ru) * 2004-12-23 2010-11-27 Колгейт-Палмолив Компани КОМПОЗИЦИЯ ДЛЯ УХОДА ЗА ПОЛОСТЬЮ РТА, СОДЕРЖАЩАЯ ЭКСТРАКТ НЕОКИСЛЕННОЙ Camellia
US8895084B2 (en) 2004-12-23 2014-11-25 Colgate-Palmolive Company Oral care composition containing extract of unoxidized Camellia
US8609152B2 (en) * 2005-05-24 2013-12-17 Mohammad Madjid Compositions and methods for extracting and using phytochemicals for the treatment of influenza
KR100757175B1 (ko) 2005-08-23 2007-09-07 (주)아모레퍼시픽 녹차 유래의 캄페롤을 유효성분으로 함유하는 주름 개선용 및 피부 탄력 향상용 피부 외용제 조성물
MY147363A (en) * 2005-09-20 2012-11-30 Nestec Sa Water dispersible composition and method for preparing same
CN1939296B (zh) * 2005-09-29 2011-04-13 中国人民解放军军事医学科学院毒物药物研究所 一种茶多酚组合物及其制备方法
EP1928268A1 (en) * 2005-09-30 2008-06-11 DSMIP Assets B.V. Novel compositions containing polyphenols
CN100364985C (zh) * 2005-11-22 2008-01-30 三达膜科技（厦门）有限公司 树脂吸附法制备茶多酚的方法
DE102005056652A1 (de) * 2005-11-25 2007-05-31 Südzucker AG Mannheim/Ochsenfurt Präparat enthaltend eine polyphenolhaltige Zusammensetzung und Isomaltulose
RU2008140811A (ru) * 2006-03-15 2010-04-20 Пом Вандерфул, Ллс (Us) Способ использования гранатовых экстрактов для увеличения времени удвоения простатспецифического антигена
JP2009538598A (ja) * 2006-03-31 2009-11-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ 固体マトリクス、その調製プロセス及びテアフラビンの製造方法
EP1913821A1 (en) 2006-10-20 2008-04-23 Kraft Foods R & D, Inc. Zweigniederlassung München Polyphenol-rich extract from plant material
WO2008127302A2 (en) * 2006-10-27 2008-10-23 Genyous BioMed International, Inc. Compositions for treatment and inhibition of pain
US20080138481A1 (en) * 2006-12-07 2008-06-12 Chi-Tang Ho Methods of reducing reactive carbonyl species
EP2106217B1 (en) * 2006-12-12 2019-03-13 Firmenich S.A. Active ingredient delivery system with an amorphous metal salt as carrier
CN101284022B (zh) * 2007-06-01 2011-06-15 山西省农业科学院农产品综合利用研究所 植物多酚类物质的络合萃取方法
US20090048187A1 (en) * 2007-07-30 2009-02-19 Luigi Ricciardiello Chemopreventive, Anticancer and Anti-Inflammatory Effects of Pinoresinol-Rich Olives
CN101121705B (zh) * 2007-09-21 2010-12-08 江苏德和生物科技有限公司 茶多酚制备工艺
EP2070429A1 (de) 2007-12-13 2009-06-17 Cognis IP Management GmbH Oxidative Stabilisierung von Sterolen und Sterolestern
JP2011520869A (ja) * 2008-05-15 2011-07-21 フイルメニツヒ ソシエテ アノニム 活性成分のためのデリバリーシステム
RU2395281C2 (ru) * 2008-09-04 2010-07-27 Всеволод Иванович Киселев Фармацевтическая композиция для лечения диспластических процессов шейки матки
JP4565219B2 (ja) * 2008-12-26 2010-10-20 アサヒビール株式会社 ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
RU2399653C1 (ru) * 2009-04-02 2010-09-20 Дамир Фаритович Маджитов Способ стабилизации пищевого продукта, содержащего жир или масло
KR101171832B1 (ko) 2009-10-30 2012-08-14 박경식 부작용을 제거한 장기간 복용 차 및 그 조성물
RU2437671C1 (ru) * 2010-06-11 2011-12-27 Сергей Владимирович Енгашев Способ очистки экстракта зеленого чая, лекарственное средство на его основе и способ профилактики и лечения заболеваний кожи
RU2437672C1 (ru) * 2010-06-11 2011-12-27 Сергей Владимирович Енгашев Способ очистки экстракта зеленого чая, лекарственное средство на его основе и способ профилактики и лечения заболеваний кожи
US20130261136A1 (en) * 2010-10-13 2013-10-03 Yi-Fang Chu Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics
US20120121721A1 (en) * 2010-11-16 2012-05-17 Michael James Skin care products and compositions
US9316580B2 (en) 2011-03-21 2016-04-19 Coloright Ltd. Systems for custom coloration
CN107361508B (zh) 2011-03-21 2020-11-03 卡拉莱特有限公司 定制染色系统
WO2013086518A1 (en) * 2011-12-09 2013-06-13 Mary Kay Inc. Skin care formulation
US10302495B2 (en) 2013-09-26 2019-05-28 Coloright Ltd. Hair reader, dispenser device and related systems and methods
WO2015166340A2 (en) 2014-04-27 2015-11-05 Coloright Ltd. Apparatus and method for analyzing hair and/or predicting an outcome of a hair-coloring treatment
CN106572736B (zh) 2014-04-27 2020-01-31 卡拉莱特有限公司 用于定制毛发染色的方法与装置
JP6730788B2 (ja) * 2015-08-31 2020-07-29 花王株式会社 精製カテキン類含有組成物の製造方法
FR3061176B1 (fr) * 2016-12-22 2020-09-11 Antofenol Preparation d'un extrait de biomasse seche riche en polyphenols
US10292482B2 (en) 2017-01-06 2019-05-21 Coloright Ltd. Hair-holder, hair-reader comprising the same, and methods for optically acquiring data from hair
CN106626941A (zh) * 2017-03-22 2017-05-10 王培彪 复方茶泥及利用该复方茶泥制备的室内装饰艺术品
US10543158B2 (en) 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
KR20190048502A (ko) * 2017-10-31 2019-05-09 (주)아모레퍼시픽 성분 함량이 변화된 차 추출물을 포함하는 순환기 질환 개선용 조성물
JP7480063B2 (ja) * 2018-05-28 2024-05-09 アネロテック・インコーポレイテッド バイオベース医薬及び患者コンプライアンスを向上させる方法
CN112090402A (zh) * 2020-08-13 2020-12-18 咖法科技(上海)有限公司 一种茶叶渣混合硅胶及其制备方法
CN118987681B (zh) * 2024-09-12 2025-11-04 昆明理工大学 一种低共熔溶剂及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2637197C2 (de) * 1976-08-18 1983-01-27 Hag Ag, 2800 Bremen Verfahren zum Entzug von Coffein aus coffeinhaltigen Naturstoffen mit einem überkritischen Extraktionsmittel
US4315036A (en) * 1978-01-12 1982-02-09 Societe D'assistance Technique Pour Produits Nestle S.A. Process for decaffeinating tea
US4331694A (en) * 1978-12-26 1982-05-25 Union Carbide Corporation Removal of caffeine by selective adsorption using zeolite adsorbents
JPS55105677A (en) * 1979-02-07 1980-08-13 Norin Suisansyo Chiyagiyou Shikenjo Production of catechins
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
US4521438A (en) * 1983-09-29 1985-06-04 General Foods Corporation Coffee extract decaffeination method
EP0167399A3 (en) * 1984-07-06 1987-08-26 General Foods Corporation Decaffeination of fermented unfired tea
JPS63214183A (ja) * 1987-03-03 1988-09-06 Mitsui Norin Kk アンジオテンシン１変換酵素阻害剤
JPH0327248A (ja) * 1989-06-22 1991-02-05 Itouen:Kk 脱カフェイン茶液の製造方法
JPH03228664A (ja) * 1990-02-02 1991-10-09 Meiji Seika Kaisha Ltd 脂質の消化吸収抑制機能を有する食品
JP3027248B2 (ja) 1991-10-02 2000-03-27 沖電気工業株式会社 アッシング方法及びその装置
CA2159465A1 (en) * 1993-04-01 1994-10-13 Paul H. Todd, Jr. Lipid-soluble green tea catechin antioxidant solutions
US5443709A (en) * 1993-12-17 1995-08-22 Imsco, Inc. Apparatus for separating caffeine from a liquid containing the same
JP3504309B2 (ja) * 1993-12-22 2004-03-08 三井農林株式会社 低カフェイン含有茶ポリフェノールの製造法
CN1097411A (zh) * 1994-05-19 1995-01-18 浙江医科大学 一种脱咖啡碱的茶多酚的生产方法
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
JP3228664B2 (ja) * 1995-09-04 2001-11-12 株式会社東芝 車両用制御装置
US6063428A (en) * 1996-02-26 2000-05-16 The Procter & Gamble Company Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
US5910308A (en) * 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis

Also Published As

Publication number Publication date
ITMI950493A1 (it) 1996-09-14
ATE222113T1 (de) 2002-08-15
NO326762B1 (no) 2009-02-09
CN1178467A (zh) 1998-04-08
US6096359A (en) 2000-08-01
JP2002187848A (ja) 2002-07-05
NO974188L (no) 1997-09-11
ITMI950493A0 (it) 1995-03-14
AU696676B2 (en) 1998-09-17
DK0814823T3 (da) 2002-11-04
WO1996028178A1 (en) 1996-09-19
AU5004096A (en) 1996-10-02
KR19980702962A (ko) 1998-09-05
CA2215210C (en) 2002-06-25
CN1138552C (zh) 2004-02-18
DE69622998D1 (de) 2002-09-19
EP0814823A1 (en) 1998-01-07
JPH10512582A (ja) 1998-12-02
US5989557A (en) 1999-11-23
JP3264934B2 (ja) 2002-03-11
PT814823E (pt) 2002-11-29
DE69622998T2 (de) 2003-04-24
CA2215210A1 (en) 1996-09-19
RU2185070C2 (ru) 2002-07-20
EP0814823B1 (en) 2002-08-14
IT1275905B1 (it) 1997-10-24
KR100301678B1 (ko) 2001-10-27
NO974188D0 (no) 1997-09-11

Similar Documents

Publication Publication Date Title
ES2136247T3 (es) Formas de dosificacion oral de azitromicina que no muestran un efecto alimento adverso.
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
ES2170918T3 (es) Inhibidor de proteina quinasa c sustituidos con halo.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ES2081110T3 (es) Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion.
MX9400166A (es) Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso.
DK1032363T3 (da) Leveringssystem med konjugeret linolsyre i kosmetiske præparater
MX9709874A (es) N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
ITMI950493A0 (it) Frazioni polifenoliche di te' loro uso e formulazioni che le contengono
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
ES2163896T3 (es) Composiciones para aumentar la concentracion y/o motilidad de los espermatozoos en humanos.
DE60116359D1 (de) Kahalalid f formulierung
PA8469101A1 (es) Ligandos azabiciclicos de receptores 5ht1
ES2157524T3 (es) Diselenuros y selenosulfuros utilizables como agentes antioxidantes.
AR026491A1 (es) Composiciones cosmeticas que contienen extracto de semillas de anis en combinacion con retinoides
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
HN1999000196A (es) Derivados de indol
AR007165A1 (es) Composición farmacéutica para uso oral que contiene diclofenac.
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.